We are live on
!
Find out more
X4 Pharmaceuticals
XFOR
XFOR
84 hedge funds and large institutions have $388M invested in X4 Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
64% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 11
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
8% more capital invested
Capital invested by funds: $358M → $388M (+$30.4M)
6% more funds holding
Funds holding: 79 → 84 (+5)
1.01% more ownership
Funds ownership: 102.28% → 103.28% (+1%)
4% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 23
Holders
84
Holders Change
+5
Holders Change %
+6.33%
% of All Funds
1.03%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
18
Increased
22
Reduced
23
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$4.97M |
| 2 |
Morgan Stanley
New York
|
+$4.72M |
| 3 |
Millennium Management
New York
|
+$4.32M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.12M |
| 5 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$2.46M |
